Menu
Back to Journals » OncoTargets and Therapy » Volume 16
Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect [Corrigendum]
Received 14 February 2023
Accepted for publication 14 February 2023
Published 1 March 2023 Volume 2023:16 Pages 141—142
Yan X, Liu SM, Liu C. Onco Targets Ther. 2022;15:1355–1368
The authors have advised that Xing Yan and Shan Mei Liu should be considered as equally contributed authors for this paper titled “Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect” published in OncoTargets and Therapy on November 10, 2022.
The updated author list should read as follows:
Xing Yan1,* Shan Mei Liu2,*, Changhong Liu1
1The Second Affiliated Hospital of Dalian Medical University, Dalian, 116000, People’s Republic of China; 2Inner Mongolia Medical University, Hohhot, 150110, People’s Republic of China
Correspondence: Changhong Liu, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116000, People’s Republic of China, Tel +86 17709870870, Email [email protected]
*These authors contributed equally to this work
The authors apologize for this oversight.
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.